Pharma Pulse
search-icon

Tag: FDA ANDA requirements

FDA Stability Testing for Generics: Requirements, Protocols & 2026 Updates

FDA Stability Testing for Generics: Requirements, Protocols & 2026 Updates

Posted On May 1, 2026 0

A comprehensive guide to FDA stability testing requirements for generic drugs, covering ICH Q1A(R2) protocols, batch specifications, common rejection reasons, and 2026 regulatory updates.

MOST POPULAR

Sulfonamide Allergies and Cross-Reactivity: What to Avoid

Sulfonamide Allergies and Cross-Reactivity: What to Avoid

Posted On August 9, 2026
Bioequivalence Studies: What FDA Requires Manufacturers to Prove

Bioequivalence Studies: What FDA Requires Manufacturers to Prove

Posted On February 22, 2026
FDA Biosimilar Approval: How the Review Process Works in 2026

FDA Biosimilar Approval: How the Review Process Works in 2026

Posted On August 23, 2026
Antibiotics for Bacterial Infections: Classes and How They Work

Antibiotics for Bacterial Infections: Classes and How They Work

Posted On January 26, 2026
Adjusting Medication Dose: Finding Your Optimal Balance of Benefits and Risks

Adjusting Medication Dose: Finding Your Optimal Balance of Benefits and Risks

Posted On January 28, 2026

Categories

  • Health (214)
  • Health Economics (18)

ARCHIVES

  • September 2026 (2)
  • August 2026 (12)
  • July 2026 (15)
  • June 2026 (12)
  • May 2026 (13)
  • April 2026 (7)
  • March 2026 (11)
  • February 2026 (11)
  • January 2026 (26)
  • December 2025 (29)
  • November 2025 (18)
  • October 2025 (30)
Pharma Pulse

Menu

  • About Pharma Pulse Weekly
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact Us

Recent Posts

Sulfonamide Allergies and Cross-Reactivity: What to Avoid

Sulfonamide Allergies and Cross-Reactivity: What to Avoid

Posted On August 9, 2026
Bioequivalence Studies: What FDA Requires Manufacturers to Prove

Bioequivalence Studies: What FDA Requires Manufacturers to Prove

Posted On February 22, 2026
© 2026. All rights reserved.